Professor Kumar and his colleagues question the use of the syndromic approach for the treatment of patients presenting with genital ulcer disease (GUD), (Genitourin Med 1995; 71:197) . Their There appears to be an unfortunate polarisation amongst physicians involved in the care of STD patients between those who advocate and those who oppose syndromic case management. This debate has echoes in broader and frequently acrimonious debates about the role of clinical guidelines in contemporary medicine. On the one hand stand a conservative lobby of traditional specialist venereologists who vigorously defend their clinical autonomy and strive to maintain high standards for a small number of patients. They tend to view the innovative public health approach to STD control advocated by the WHO as an encroachment on their specialist territory and an imposition by non-specialist epidemiologists. On the other hand stands a more radical, public-health oriented group who point out the inability of traditional specialist clinic based services to make any real impact on the huge burden of STDs in developing countries and, in particular on the rapid spread of HIV, and who argue that the routine management of common STDs must be made an essential skill for primary health care workers in settings where the prevalence of STDs is high. I would like to make a plea for those on both sides of the divide to acknowledge that we still do not know which of the currently available approaches to STD case management has the most favourable impact on control and that all those involved in the care of STD patients have a responsibility to try and develop new models of care and to carry out well-designed studies to compare the efficacy of newer and older approaches to STD case management which can be used to guide future policy. These women were apparently carrying chlamydia in the urethra.
We have tried to reproduce these results using the Syva Chlamydia enzyme immunoassay (EIA) to screen samples, and direct immunofluorescence of the centrifuged deposit to confirm (Syva DFA).
Two hundred women presenting with a new episode were screened by taking both a cervical and a urethral swab for chlamydia. The prevalence was 5-5% (11 of 200), which was lower than Hay et al's 29%, but more compatible with the 5-10% figure which they quote as normal for clinic attenders. Of the 11 confirmed chlamydia positive samples, 7 were from the cervix only, 2 were from the urethra only, and 2 were from both the cervix and urethra. Thus, 2 of 11 cases of chlamydia would have been missed.
In addition to this study, we carried out a survey of clinics to assess standard practice since the publication of Hay et al's paper, and the results suggest little change from traditional cervical swabbing alone.
Larger genitourinary medicine centres in the UK were circulated with a questionnaire containing two questions:- 
